Addressing uncertainties about the effects of treatments offered to NHS patients: whose responsibility?
暂无分享,去创建一个
[1] K. Chalkidou,et al. Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of research , 2007, Journal of the Royal Society of Medicine.
[2] T. Evans. Best research for best health: a new national health research strategy. , 2006, Clinical medicine.
[3] T. Sheldon. What's the evidence that NICE guidance has been implemented?: Authors' reply , 2005, BMJ : British Medical Journal.
[4] I. Chalmers,et al. Is the NHS willing to help clinicians and patients reduce uncertainties about the effects of treatments? , 2005, Clinical medicine.
[5] C. Sudlow,et al. Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis , 2003, BMJ : British Medical Journal.
[6] M McClarey,et al. Implementing NICE guidance. , 2001, Professional nurse.
[7] I. Chalmers. It's official: Evaluative research must become part of routine care in the NHS , 2000, Journal of the Royal Society of Medicine.
[8] J. Dixon,et al. The NHS plan , 2000, BMJ : British Medical Journal.
[9] R. Collins,et al. WHICH ANTICONVULSANT FOR WOMEN WITH ECLAMPSIA - EVIDENCE FROM THE COLLABORATIVE ECLAMPSIA TRIAL , 1995 .
[10] The Surfaxin-Lavage for Mas Trial Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial , 1995, The Lancet.
[11] London,et al. General Medical Council , 1920 .
[13] J. TilleyC,et al. What's the evidence that NICE guidance has been implemented? , 2005 .